US Patent Issued to PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG-PRIVATSTIFTUNG on Oct. 20 for "Mesenchymal stem cell-derived extracellular vesicles and their medical use" (Austrian Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,166, issued on Oct. 20, was assigned to PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG-PRIVATSTIFTUNG (Salzburg, Austria).

"Mesenchymal stem cell-derived extracellular vesicles and their medical use" was invented by Andreas Traweger (Burmoos, Austria) and Mario Gimona (Anif, Austria).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for obtaining extracellular vesicles derived from mesenchymal stromal cells (MSCs), wherein the extracellular-vesicles are essentially free of vesicles not derived from the MSCs, and wherein the extracellular-vesicles are essentially free of heparin. The invention further relates...